Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck/Pfizer's Latest SGLT-2 Data Support Attractive Ertugliflozin/Januvia Combo

Sep 16 2016

• By Emily Hayes

shelves

Related Content

ADA: Diabetes Duo Merck & Pfizer Report Positive PhIII Data For Investigational SGLT-2

Jun 11 2016

<em>Januvia</em> Gains Another Boost With FDA Warnings for <em>Onglyza</em>, <em>Nesina</em>

Apr 11 2016

Invokana, Farxiga New Safety Warning May Give Jardiance Market Edge

Jun 16 2016

Related Companies

Johnson & Johnson

AstraZeneca PLC

Takeda Pharmaceutical Co. Ltd.

Additional Topics

Research & Development Clinical Trials Metabolic Disorders BioPharmaceutical

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window